Source: Bioorganic & Medicinal Chemistry. Unidade: FCF
Subjects: STAPHYLOCOCCUS (RESISTÊNCIA), DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, QUIMIOTERÁPICOS
ABNT
PAULA, Fávero Reisdorfer et al. Molecular modeling studies and in vitro bioactivity evaluation of a set of novel 5-nitro-heterocyclic derivatives as anti-T. cruzi agents. Bioorganic & Medicinal Chemistry, v. 17, n. 7, p. 2673-2679, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2009.02.056. Acesso em: 01 nov. 2024.APA
Paula, F. R., Jorge, S. D., Almeida, L. V. de, Pasqualoto, K. F. M., & Tavares, L. C. (2009). Molecular modeling studies and in vitro bioactivity evaluation of a set of novel 5-nitro-heterocyclic derivatives as anti-T. cruzi agents. Bioorganic & Medicinal Chemistry, 17( 7), 2673-2679. doi:10.1016/j.bmc.2009.02.056NLM
Paula FR, Jorge SD, Almeida LV de, Pasqualoto KFM, Tavares LC. Molecular modeling studies and in vitro bioactivity evaluation of a set of novel 5-nitro-heterocyclic derivatives as anti-T. cruzi agents [Internet]. Bioorganic & Medicinal Chemistry. 2009 ; 17( 7): 2673-2679.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.bmc.2009.02.056Vancouver
Paula FR, Jorge SD, Almeida LV de, Pasqualoto KFM, Tavares LC. Molecular modeling studies and in vitro bioactivity evaluation of a set of novel 5-nitro-heterocyclic derivatives as anti-T. cruzi agents [Internet]. Bioorganic & Medicinal Chemistry. 2009 ; 17( 7): 2673-2679.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.bmc.2009.02.056